Factors associated with interruption of treatment among pulmonary tuberculosis patients in plateau state, Nigeria. 2011

Pan African Medical Journal

Volumn 17, Issue , 2014, Pages

  Ibrahim, Luka Mangveep ^a   Hadejia, Idris Suleiman ^b   Nguku, Patrick ^a   Dankoli, Raymond ^a   Waziri, Ndadilnasiya Endie ^a   Akhimien, Moses Obiemen ^a   Ogiri, Samuel ^c   Oyemakinde, Akin ^a   Dalhatu, Ibrahim ^d   Nwanyanwu, Okey ^d   Nsubuga, Peter ^e  

^a Ahmadu Bello University ^*

^b AHMADU BELLO UNIVERSITY   (Nigeria)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Global Public Health Solution   (United States)

Author keywords

Interruption; Nigeria; Treatment; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; DIRECTLY OBSERVED THERAPY; EPIDEMIOLOGY; FEMALE; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HUMAN; INCIDENCE; INFORMATION PROCESSING; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NIGERIA; PATIENT EDUCATION; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; ATTITUDE OF HEALTH PERSONNEL; DIRECTLY OBSERVED THERAPY; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; INCIDENCE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NIGERIA; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84893611746     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.11604/pamj.2014.17.78.3464     Document Type: Article

References (21)

1. Federal Ministry of Health Abuja Nigeria. National TB and leprosy control program workers manual 5th edition. September 2008. Nigeria. Federal Ministry of Health Abuja Nigeria.
2. WHO. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. Geneva. WHO.
3. Plateau State Ministry of Health. Annual report, Plateau state TB and leprosy Control Program. 2011. Nigeria. Plateau State Ministry of Health.
4. Federal Ministry of Health, Abuja Nigeria. National TB and leprosy control program, National Drug-resistant Tuberculosis prevalence survey. August 2012. Nigeria. Federal Ministry of Health.
5. State Ministry of Health. Plateau state health bulletin. 2008. Nigeria. State Ministry of Health.
6. OBoyle SJO, Power JJ, Ibrahim MY, Watson JP. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis. 2002; 6(4):307-312.
7. Kandel TR, Mfenyana K, Chandia J, Yogeswaran P. The prevalence of and reasons for interruption of anti-tuberculosis treatment by patients at Mbekweni Health Centre in the King Sabata Dalindyebo (KSD) District in the Eastern Cape Province. SA Fam Pract. 2008;50(6):47.
8. Kaona FAD, Tuba M, Siziya S, and Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004; 4: 68.
9. Jaiswal A, Singh V, Ogden J A, Porter JDH et al. Adherence to tuberculosis treatment: lesson from the urban setting of Delhi, India. Tropical Medicine and International Health. 2003; 8(7): 625-633.
10. Wu P, Chou P, Chang N, Sun W, Kuo H. Assessment of Changes in Knowledge and Stigmatization Following Tuberculosis Training Workshops in Taiwan. J Formos Med Assoc. 2009; 108 (5): 349-435.
11. Karima F, Ahmed F, Begun I, Johnson E and Diwan VK. Female-male differences at various clinical step of TB treatment. Int J Tuberc Lung Dis. 2008; 12 (11): 1336-9.
12. Begum V, de Colombani P, Das Gupta S et al. Tuberculosis and patient gender in Bangladesh: sex differences in diagnosis and treatment outcome. Int J Tuberc Lung Dis. 2001; July; 5(7), 604-610.
13. Bashour H and Mamaree F. Gender differences and tuberculosis in the Syrian Arab Republic: patients? attitudes, compliance and outcomes. Eastern Mediterranean Health Journal. 2003; 9(4): 757.
14. Schneider NK and Novotny T E. Addressing smoking cessation in tuberculosis control. Bull World Health Organ. 2007; 85(8):647-8.
15. Tachfouti N, Nejjari C, Benjelloun MC, Berraho M et al. Association between smoking status, other factors and tuberculosis treatment failure in Morocco. Int J Tuberc Lung Dis. 2011; (6):836-43.
16. Santha T, Garg R, Frieden TR et al. Risk factors associated with default, failure and death among TB patients. Int J Tuberc Dis. 2003; Feb 7(2):200-1.
17. Balbay O, Annakaya AN, Arbak PBilgin C and Erbas M. Which patient are able to adhere to Tuberculosis treatment: A study in rural area in the North west part of Turkey. Jpn J Infect Dis. 2005; 58(3): 152-158.
18. Bagchi S, Ambe G, Sathiakumar N. Determinants of Poor Adherence to Anti-Tuberculosis Treatment in Mumbai, India. Int J Prev Med. 2010; 1(4): 223-232.
19. Hasker E, Khodjikhanov M, Usarova S, Asamidinov U et al. Default from tuberculosis treatment in Tashkent, Uzbekistan: Who are these defaulters and why do they default. BMC Infectious Diseases. 2008; 8:97.
20. Vijay S, Balasangameswara VH, Jagannatha P S, Saroja VN and Kumar P. Defaults among tuberculosis patients treated under DOTS in Bangalore city: a search for solution. Ind J Tub. 2003; 50 (185).
21. Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C et al. Reasons for non-compliance among patients treated under revised National Tuberculosis Control Program (rntcp), Tiruvallur District, South India. Indian J Tuberc. 2007; 54(3):130-135.